Elizabeth L Hougen has sold IONS and made no open-market buys since Jan 2016

Elizabeth L. Hougen is the Executive Vice President, Finance and Chief Financial Officer of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a role she has held since April 2020.( She oversees finance, accounting, tax, treasury, information technology, procurement, and investor relations, contributing to the company's strategy for sustainable profitability.( Hougen joined Ionis in May 2000 as Vice President, Finance, advanced to Chief Accounting Officer in 2007, Senior Vice President, Finance & CFO in 2013, and her current position in 2020.( Prior to Ionis, she served as Executive Director, Finance and CFO at Molecular Biosystems, Inc., a public biotechnology company.(

Hougen holds a B.A. in Business from Franklin & Marshall College and an M.B.A. from the University of San Diego.( In recognition of her contributions, she was named a CFO of the Year by the San Diego Business Journal in 2018.( Recently, on January 30, 2026, she sold 6,988 shares of Ionis stock for approximately $581,702 following a vesting of performance-based restricted stock units, retaining 132,881 shares.( She also serves as a Director at Artiva Biotherapeutics.(

Written by Perplexity from public sources.